A Role for Notch Signalling in Breast Cancer and Endocrine Resistancesssss

被引：47
作者：
Acar, Ahmet [1 ]
Simoes, Bruno M. [2 ]
Clarke, Robert B. [2 ,3 ]
Brennan, Keith [1 ]
机构：
[1] Univ Manchester, Fac Life Sci, Oxford Rd, Manchester M13 9PT, Lancs, England
[2] Univ Manchester, Inst Canc Sci, Breast Biol Grp, Wilmslow Rd, Manchester M20 4BX, Lancs, England
[3] Univ Manchester, Inst Canc Sci, Breast Canc Now Res Unit, Wilmslow Rd, Manchester M20 4BX, Lancs, England
来源：
STEM CELLS INTERNATIONAL | 2016年 / 2016卷
关键词：
ESTROGEN-RECEPTOR; STEM-CELLS; TUMOR ANGIOGENESIS; DOMAIN MUTATIONS; ACTIVATION; EXPRESSION; GENE; MODULATION; TAMOXIFEN; THERAPY;
D O I：
10.1155/2016/2498764
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Over the past decade, there has been growing interest in the Notch signalling pathway within the breast cancer field. This interest stemmed initially from the observation that Notch signalling is aberrantly activated in breast cancer and its effects on various cellular processes including proliferation, apoptosis, and cancer stem cell activity. However more recently, elevated Notch signalling has been correlated with therapy resistance in oestrogen receptor-positive breast cancer. As a result, inhibiting Notch signalling with therapeutic agents is being explored as a promising treatment option for breast cancer patients.
引用
收藏
页数：6
相关论文
共 60 条
[1]   Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[2]   Endocrine-responsive breast cancer and strategies for combating resistance [J].
Ali, S ;
Coombes, RC .
NATURE REVIEWS CANCER, 2002, 2 (02) :101-+
[3]  
Carlson Robert W, 2005, Clin Breast Cancer, V6 Suppl 1, pS5, DOI 10.3816/CBC.2005.s.008
[4]   Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer [J].
Cohen, Brenda ;
Shimizu, Mamiko ;
Izrailit, Julia ;
Ng, Nancy F. L. ;
Buchman, Yuri ;
Pan, James G. ;
Dering, Judy ;
Reedijk, Michael .
BREAST CANCER RESEARCH AND TREATMENT, 2010, 123 (01) :113-124
[5]   Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features [J].
Creighton, Chad J. ;
Li, Xiaoxian ;
Landis, Melissa ;
Dixon, J. Michael ;
Neumeister, Veronique M. ;
Sjolund, Ashley ;
Rimm, David L. ;
Wong, Helen ;
Rodriguez, Angel ;
Herschkowitz, Jason I. ;
Fan, Cheng ;
Zhang, Xiaomei ;
He, Xiaping ;
Pavlick, Anne ;
Gutierrez, M. Carolina ;
Renshaw, Lorna ;
Larionov, Alexey A. ;
Faratian, Dana ;
Hilsenbeck, Susan G. ;
Perou, Charles M. ;
Lewis, Michael T. ;
Rosen, Jeffrey M. ;
Chang, Jenny C. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (33) :13820-13825
[6]  
Dang TP, 2012, ADV EXP MED BIOL, V727, P199, DOI 10.1007/978-1-4614-0899-4_15
[7]   A new genome-driven integrated classification of breast cancer and its implications [J].
Dawson, Sarah-Jane ;
Rueda, Oscar M. ;
Aparicio, Samuel ;
Caldas, Carlos .
EMBO JOURNAL, 2013, 32 (05) :617-628
[8]   High-level JAG1 mRNA and protein predict poor outcome in breast cancer [J].
Dickson, Brendan C. ;
Mulligan, Anna Marie ;
Zhang, Hui ;
Lockwood, Gina ;
O'Malley, Frances P. ;
Egan, Sean E. ;
Reedijk, Michael .
MODERN PATHOLOGY, 2007, 20 (06) :685-693
[9]   Association of reactive oxygen species levels and radioresistance in cancer stem cells [J].
Diehn, Maximilian ;
Cho, Robert W. ;
Lobo, Neethan A. ;
Kalisky, Tomer ;
Dorie, Mary Jo ;
Kulp, Angela N. ;
Qian, Dalong ;
Lam, Jessica S. ;
Ailles, Laurie E. ;
Wong, Manzhi ;
Joshua, Benzion ;
Kaplan, Michael J. ;
Wapnir, Irene ;
Dirbas, Frederick M. ;
Somlo, George ;
Garberoglio, Carlos ;
Paz, Benjamin ;
Shen, Jeannie ;
Lau, Sean K. ;
Quake, Stephen R. ;
Brown, J. Martin ;
Weissman, Irving L. ;
Clarke, Michael F. .
NATURE, 2009, 458 (7239) :780-U123
[10]   The impact of tumor stroma on drug response in breast cancer [J].
Dittmer, Juergen ;
Leyh, Benjamin .
SEMINARS IN CANCER BIOLOGY, 2015, 31 :3-15
123456